Back to IDIX Stock Lookup
Pages: 1 2 »» Last Page


Apr 7, 2014 07:52 AM Idenix Pharma (IDIX) Updates on IDX21437 in HCV; Plans mid-2014 Initiation of Phase II with Samatasvir
Mar 24, 2014 07:02 AM Idenix Pharma (IDIX) to Challenge Norway Patent Decision
Jan 29, 2014 05:12 PM Idenix Pharma (IDIX) Reports Adverse Ruling in Patent Case with Gilead (GILD)
Jan 13, 2014 07:21 AM Idenix Pharma (IDIX) Issues Encouraging Update on k HELIX-1 Phase II
Jan 6, 2014 08:13 AM Idenix Pharma (IDIX) Taps AstraZeneca's (AZN) Dumas as Scientific Chief
Dec 9, 2013 08:05 AM Idenix Pharma (IDIX) Reports HCV Treatment Patent Interference (GILD)
Dec 2, 2013 07:17 AM Idenix Pharma (IDIX) Files Two New Patent Suits Against Gilead (GILD)
Dec 2, 2013 07:16 AM Idenix Pharma (IDIX) Begins Enrollment in HELIX-2 Phase 2
Oct 1, 2013 02:01 PM Idenix Pharma (IDIX) Will Present Data on IDX20963 as HCV Treatment at AASLD
Jun 20, 2013 04:10 PM FDA Requests More Info from Idenix (IDIX) for IDX20963
May 30, 2013 08:01 AM Idenix Pharma (IDIX) Initiates Phase II HELIX-1
Mar 22, 2013 04:15 PM Idenix Pharma (IDIX) Receives Adverse Decision in HCV Patent Filing; Will Appeal
Feb 4, 2013 04:10 PM Idenix Pharma (IDIX) to Cease IDX184, IDX19368 Programs
Jan 28, 2013 07:01 AM Idenix (IDIX) Enters Collaboration with Janssen Pharma for DAA HCV Evaluatlion
Nov 12, 2012 07:54 AM Idenix Pharmaceuticals (IDIX) Reports Clinical Data For HCV Drugs
Sep 20, 2012 08:17 AM Idenix (IDIX) Updates Investor Presentation Related to IDX184 Partial Clinical Hold and Additional Data Requests
Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead
Aug 27, 2012 08:56 AM Idenix Pharma (IDIX) Peers on Watch as FDA Places Clinical Hold on Another HCV Treatment (ACHN) (GILD)
Aug 27, 2012 08:31 AM Idenix Pharma (IDIX) Says Clinical Hold Placed on IDX19368 by FDA
Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution
Aug 17, 2012 07:45 AM Jefferies Maintains a 'Hold' on Gilead Sciences (GILD); We Don't Believe
Aug 16, 2012 09:50 AM Idenix (IDIX) News Shakes-Up Hep C Sector (VRTX) (GILD) (BMY) (ACHN)
Aug 16, 2012 08:54 AM Gilead Sciences (GILD) On Watch on Idenix News
Aug 16, 2012 08:08 AM UPDATE: Idenix (IDIX) IDX184 Placed on Partial Clinical Hold After Serious Cardiac-Related Event
Jul 25, 2012 08:31 AM Idenix Pharma (IDIX) Reports IDX719 Gets FDA Fast Track Designation
Jun 19, 2012 04:09 PM Idenix Pharma (IDIX) Updates on Ongoing Phase IIb for IDX184 in Combo w/ PegIFN/RBV
Apr 19, 2012 09:21 AM Idenix Pharma (IDIX) Rips, Reports Encouraging Data from IDX719 Phase I
Feb 17, 2012 07:11 AM Gilead Sciences (GILD) Data Shakes-Up Hep-C Space (VRTX) (IDIX) (ACHN)
Feb 3, 2012 08:06 AM FDA Removes Partial Clinical Hold from Idenix Pharma's (IDIX) IDX184
Feb 3, 2012 08:04 AM Idenix (IDIX) announces removal of partial clinical hold on HCV nucleotide inhibitor, IDX184
Jan 9, 2012 07:08 AM Idenix Pharma (IDIX) Updates on HCV Treatment Pipeline; Initiates IDX719 Phase I
Jan 9, 2012 07:07 AM Idenix Pharma (DIX) Says IDX184 Demonstrated High Level of Resistance to In Vitro, Antiviral Acitivity
Dec 16, 2011 09:22 AM Vertex (VRTX) Higher After Pharmasset (VRUS) Hep-C Trial Issues
Dec 16, 2011 08:30 AM Watch Other Hep C Drug Makers on Pharmasset (VRUS) QUANTUM News: INHX IDIX ACHN
Feb 9, 2011 05:19 PM Idenix Pharma (IDIX) Updates on Three Developments; FDA Hold on IDX184 Removed
Nov 23, 2010 08:02 AM Idenix Pharma (IDIX) Receives $20M Milestone in GSK2248761 Development
Sep 7, 2010 07:42 AM Idenix Pharma (IDIX) Shares Resume Trading Down Almost 55%
Sep 7, 2010 07:16 AM Idenix Pharma (IDIX) Receives Clinical Hold from U.S. FDA for IDX184 and IDX320 Programs
Jul 26, 2010 04:11 PM Idenix Pharma (IDIX) Posts Q2 Loss of $0.23, Wider than Views; Updates on Hepatitis C Virus Programs
Jun 10, 2010 08:08 AM Idenix Pharma (IDIX) Initiates Concept Study for IDX320 in HCV Genotype-1 Infected Patients
Apr 16, 2010 06:59 AM Idenix Pharma (IDIX) Announces Positive IDX320 Phase I Data
Apr 15, 2010 06:53 AM Idenix Pharma (IDIX) To Present Data from IDX184 Phase IIa
Jan 11, 2010 07:59 AM Idenix Pharma (IDIX) Announces Progress in Three HCV Programs; Updates on FY09 Guidance
Feb 6, 2009 07:12 AM Idenix (IDIX) Enters License Agreement With GlaxoSmithKline For HIV Treatment IDX899
Jan 12, 2009 09:51 AM Idenix Pharmaceuticals (IDIX) Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
Feb 6, 2008 05:36 PM Idenix (IDIX) Demonstrates Inhibition of HIV Replication in a Phase I/II Clinical Trial
Jul 13, 2007 08:59 AM Idenix Pharmaceuticals (IDIX) Says FDA Placed Clinical Hold on Valopicitabine Development Program
Jun 12, 2007 08:24 AM Idenix Pharmaceuticals (IDIX) Higher After Positive Phase II Study Results
Apr 30, 2007 09:09 AM Idenix Pharmaceuticals (IDIX) Higher on European Approval for SEBIVO
Pages: 1 2 »» Last Page

Back to IDIX Stock Lookup